A spin-off from biotech company Bioneer, AceBiome took home the award with its BNRThin/BNRThin pro weight management probiotic.
According to AceBiome founder and CEO Myeong Hee Kim, the product uses the patented lactobacillus gasseri BNR17 strain that the parent company had isolated from human breast milk.
As an ingredient, BNR17 also won the weight management Ingredient of the Year two years ago in the US version of the award.
The company is now working on expanding the functionality of its probiotics and works are underway in developing a probiotic for cognitive health.
“People live longer these days, and cognitive health becomes more important than ever for older adults. We want to help them age healthily with our products,” Kim said.
However, it will take about a year or two for the product to enter the market, she said.
Recently, the company also launched BNR Queen, a new product for addressing menopausal symptoms and aiding weight management at the same time.
Aside from BNR17, the product also uses sophoricoside as one of its key active ingredients.
We’ll be shining the spotlight on Probiotics and Prebiotics in our Growth Asia 2020 interactive broadcast series, featuring expert insights from a host of big-name brands and world-renowned experts. Register for free here.
Market reach
Outside of the domestic market, the BNRThin product is about to launch in a number of new markets, including Singapore, Japan, China, and Vietnam.
On the other hand, US-based probiotic ingredient firm UAS Labs is a licensee and partner in marketing the BNR17 strain in a number of major markets. They are the North America market and China.
“We are working to expand the market so that more people across the globe can get health benefits from this novel probiotic,” Kim said.
Watch the video to find out more.
